| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/02/2003 | US20030003138 Articles with spores exhibiting antagonistic properties against pathogens and/or spores forming micro-organisms |
| 01/02/2003 | US20030003135 Article for drug delivery and methods of making and using same |
| 01/02/2003 | US20030003133 Use of milk and milk- related products as a carrier or delivery vehicle for allergens in the process of oral tolerance induction and prevent allergic conditions |
| 01/02/2003 | US20030003131 Method for manufacture of free-flowing powder containing water-dispersible sterols |
| 01/02/2003 | US20030003130 Compositions for regulating desire for smoking |
| 01/02/2003 | US20030003129 Biocompatible implants for localized delivery of pharmaceutically active agent to the posterior segment of the eye |
| 01/02/2003 | US20030003125 Composition and medical devices utilizing bioabsorbable polymeric waxes |
| 01/02/2003 | US20030003121 Antiallergic agent |
| 01/02/2003 | US20030003120 A phenolic fraction of fruit obtained from the Rosaceae family, including at least 10% by weight of the sum of phloridzin, chlorogenic acid, epicatechin, quercitrin, procyanidin B2, p-coumaric acid and caffeic acid |
| 01/02/2003 | US20030003117 Hydrolyzed whole egg products & related methods |
| 01/02/2003 | US20030003116 Skin care agent and method of skin care |
| 01/02/2003 | US20030003107 Topical compositions containing probiotic bacillus bacteria, spores, and extracellular products and uses thereof |
| 01/02/2003 | US20030003106 Use of protein derived from cancer cells, cells infected by a virus or immune cells or an inactive fragment thereof, protein being initially an immunosuppressive and/or angiogenic protein for obtaining medicines to provide mucosal immunity |
| 01/02/2003 | US20030003105 Comprising lecithin and a polymer, preferably polyacrylic acid |
| 01/02/2003 | US20030003095 Activated carbon for preventing pregnancy and sexually transmitted disease |
| 01/02/2003 | US20030003094 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule |
| 01/02/2003 | US20030003076 Adenovirus E1B-55K single amino acid mutants and methods of use |
| 01/02/2003 | US20030003074 Comprising a biodegradable block copolymeric drug carrier having thermally reversible gelation properties; sustained release of an interleukin-2, no side effects |
| 01/02/2003 | US20030003059 For prophylaxis, therapy and/or management of dental and related tissue conditions, including dental caries, dental cavities, microbial flora, tartar, periodontal and related gum diseas |
| 01/02/2003 | US20030003058 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 01/02/2003 | US20030003057 Methods for administering leuprolide by inhalation |
| 01/02/2003 | US20030003056 Useful in in vivo applications sucha as embolizing blood vessels and/or reversibly sterilizing mammals |
| 01/02/2003 | US20030003055 Shaking an aqueous solution comprising a phospholipid and a polymer, in the presence of a gas, at a temperature below the gel state to liquid crystalline transition temperature of the lipid |
| 01/02/2003 | US20030003054 Suitable for use as a contrast agent with a plurality of imaging modalities, including, for example, ultrasound, magnetic resonance imaging, and computed temography; neutron capture therapy |
| 01/02/2003 | US20030000519 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 01/02/2003 | US20030000518 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 01/02/2003 | US20030000228 Method for producing particulate goods |
| 01/02/2003 | EP1270586A2 Composition for the cell-specific transfer of active substances |
| 01/02/2003 | EP1270574A1 Caffeine complexes with improved flavour, process for their preparation and their use |
| 01/02/2003 | EP1270205A1 Adhesive sheet and adhesive preparation, and production methods thereof |
| 01/02/2003 | EP1270032A1 Device for parenterally delivering solid drug compositions |
| 01/02/2003 | EP1270024A1 Compositions and medical devices comprising bioabsorbable alkyd-type polymeric waxes |
| 01/02/2003 | EP1270013A1 Topical wound healing compositions comprising hyaluronic acid and a serine protease inhibitor |
| 01/02/2003 | EP1270012A1 Use of pulmonary administration of insulin for treatment of diabetes |
| 01/02/2003 | EP1270007A2 Microemulsions for the transdermal administration of apomorphine, for the treatment of Parkinson's disease |
| 01/02/2003 | EP1270006A2 Quinolone derivative pharmaceutical composition and production method therefor |
| 01/02/2003 | EP1270005A2 Formulation comprising amoxicillin and an organic acid |
| 01/02/2003 | EP1269999A1 Ultraviolet-shielding adhesive preparation |
| 01/02/2003 | EP1269998A1 Composition of prolonged liberation in the form of multiple granules that enables the maintenance of the therapeutic action of 4-nitro-2-phenoximethanesulfonanilide |
| 01/02/2003 | EP1269997A1 Unit dosage comprising amoxicillin and clavulanate |
| 01/02/2003 | EP1269996A1 Unit dosage comprising amoxycillin and clavulanate |
| 01/02/2003 | EP1269995A1 Easy-to-take granule |
| 01/02/2003 | EP1269994A2 Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| 01/02/2003 | EP1269993A1 Delivery of small hydrophilic molecules packaged into lipid vesicles |
| 01/02/2003 | EP1269984A1 Cosmetic and/or dermatological andor pharmaceutical composition for topical application containing at least one compound inhibiting 3-beta-HSD enzyme |
| 01/02/2003 | EP1269972A1 Hair growth stimulant compositions with sustained action |
| 01/02/2003 | EP1269860A1 Pharmaceutical composition |
| 01/02/2003 | EP1268626A1 A porous, molecularly imprinted polymer and a process for the preparation thereof |
| 01/02/2003 | EP1268591A1 Process of microgel synthesis and products produced therefrom |
| 01/02/2003 | EP1268470A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 01/02/2003 | EP1268305A1 Infusion packet with useful and decorative elements, support member, delivery system and method |
| 01/02/2003 | EP1267999A1 Stable thyroid hormone preparations and method of making same |
| 01/02/2003 | EP1267997A2 Permanent magnet keeper-shield assembly |
| 01/02/2003 | EP1267976A1 Microencapsulated fragrances and methods of coating microcapsules |
| 01/02/2003 | EP1267956A2 Injectable microspheres for dermal augmentation and tissue bulking |
| 01/02/2003 | EP1267946A2 Nanocapsule encapsulation system and method |
| 01/02/2003 | EP1267943A2 Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof |
| 01/02/2003 | EP1267935A2 Novel treatment for eye disease |
| 01/02/2003 | EP1267932A1 Anti-infective active substance combinations and the use thereof for the topical treatment of fungus diseases of toe and finger nails |
| 01/02/2003 | EP1267924A2 Immunotherapeutic methods and compositions |
| 01/02/2003 | EP1267923A1 Use of aliphatic quaternary ammonium as adjuvant in a pharmaceutical composition administered by mucosal delivery |
| 01/02/2003 | EP1267916A2 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| 01/02/2003 | EP1267913A2 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 01/02/2003 | EP1267907A1 Use of mia in immunotherapy |
| 01/02/2003 | EP1267902A1 Cosmetic use of hop and ornithine |
| 01/02/2003 | EP1267900A1 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract |
| 01/02/2003 | EP1267895A1 Use of feracryl for the treatment of peptic/duodenal ulcer and/or cholera |
| 01/02/2003 | EP1267894A2 Viscoelastics for use in middle ear surgery |
| 01/02/2003 | EP1267889A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 01/02/2003 | EP1267885A1 Male contraceptive formulation comprising norethisterone |
| 01/02/2003 | EP1267884A1 Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredients |
| 01/02/2003 | EP1267883A2 Bile secretion promoting composition containing a prostaglandin |
| 01/02/2003 | EP1267880A1 Low dose entecavir formulation and use |
| 01/02/2003 | EP1267879A2 Sustained release beadlets containing stavudine |
| 01/02/2003 | EP1267866A2 The treatment of respiratory diseases |
| 01/02/2003 | EP1267865A2 Amiodarone-containing parenteral solution |
| 01/02/2003 | EP1267864A1 A synergistic anti-malarial formulation |
| 01/02/2003 | EP1267862A2 Methods and compositions for improving sleep |
| 01/02/2003 | EP1267846A1 Transdermal therapeutic system for the delivery of lerisetron |
| 01/02/2003 | EP1267845A1 Plaster containing an active agent |
| 01/02/2003 | EP1267844A1 Sustained release vitamin composition |
| 01/02/2003 | EP1267843A1 System for transporting active substances in a biological system |
| 01/02/2003 | EP1267842A1 Method for producing a controlled-release preparation |
| 01/02/2003 | EP1267841A1 Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine |
| 01/02/2003 | EP1267840A1 Granulated particles with masked taste |
| 01/02/2003 | EP1267839A2 Microspheres for active embolization |
| 01/02/2003 | EP1267838A1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 01/02/2003 | EP1267837A1 Matrices containing nitric oxide donors and reducing agents and their use |
| 01/02/2003 | EP1267836A1 Process for the preparation of accelerated release formulations using compressed fluids |
| 01/02/2003 | EP1267835A1 D and l etherlipid stereoisomers and liposomes |
| 01/02/2003 | EP1267834A1 Cationic liposomes |
| 01/02/2003 | EP1267833A1 Pharmaceutical preparations and their manufacture |
| 01/02/2003 | EP1267832A1 New self emulsifying drug delivery system |
| 01/02/2003 | EP1267831A1 New self emulsifying drug delivery system |
| 01/02/2003 | EP1267830A2 Method for preparing high pressure/high shear dispersions containing physiologically active ingredients |
| 01/02/2003 | EP1267829A1 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 01/02/2003 | EP1267828A2 Pharmaceutical preparations |
| 01/02/2003 | EP1267827A2 Method for treating dry eye |
| 01/02/2003 | EP1267826A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/02/2003 | EP1267799A1 Cosmetic composition comprising at least a non-polymeric crystalline salt |